13 July, 2026
In a landmark move to fortify the global respiratory healthcare infrastructure, the European Respiratory Society (ERS) has officially unveiled its "Visiting Mid-Career Investigator Travel" (VISIT) Grants programme. This strategic initiative is designed to bridge the professional development gap for mid-career clinicians, investigators, and allied healthcare professionals, offering them the unique opportunity to undertake short-term professional exchanges at host institutions outside their home countries.
By fostering international mobility, the ERS aims to accelerate the exchange of clinical expertise, research methodologies, and innovative healthcare delivery models. As the respiratory health sector grapples with increasingly complex challenges—ranging from the long-term sequelae of infectious respiratory diseases to the rising burden of chronic obstructive pulmonary disease (COPD) and asthma—the need for a globally connected, highly skilled workforce has never been more urgent.
Main Facts: The Scope and Objective of the VISIT Programme
The VISIT Grants programme is specifically engineered for those in the mid-career phase—a period often characterized by the transition from established investigator or clinician to a leadership or principal investigator role. Unlike traditional long-term fellowships that may require years of commitment, the VISIT programme offers a more agile framework, allowing professionals to spend up to one month immersed in a different institutional environment.
Key Programmatic Features:
- Duration: Exchanges are capped at one month, allowing for intensive, focused collaboration without necessitating an indefinite departure from home responsibilities.
- Institutional Breadth: Recipients may carry out their visits at a wide variety of settings, including university research departments, clinical hospitals, specialized laboratories, or accredited non-profit health organizations.
- Global Accessibility: While administered by a European-based body, the programme is open to applicants worldwide, underscoring the ERS’s commitment to cross-continental knowledge sharing.
- Professional Development: The grants cover travel and subsistence, removing the financial barriers that often prevent mid-career experts from pursuing international collaborative opportunities.
The programme aims to foster a "cross-pollination" of ideas, where techniques refined in one clinical setting—such as a novel approach to bronchoscopy or a breakthrough in respiratory physiotherapy—can be disseminated to other regions, thereby elevating the standard of patient care globally.
Chronology: A Roadmap for Applicants
The ERS has established a clear timeline to ensure that the application and selection process is rigorous, transparent, and equitable.
- 13 July 2026: Official launch of the VISIT Grants programme. Prospective applicants are granted access to the online portal to review eligibility criteria and prepare documentation.
- July–October 2026: The application window is open. Applicants are encouraged to secure letters of support from host institutions and draft robust proposals detailing the educational or research objectives of their visit.
- 31 October 2026: The final deadline for all grant submissions. Applications received after this date will not be considered for the current cycle.
- Late 2026/Early 2027: Evaluation of applications by an ERS committee of experts. Selection will be based on the project’s impact, the applicant’s professional trajectory, and the potential for long-term collaboration between the home and host institutions.
- 2027: Successful candidates will embark on their exchange programmes, with final reporting required upon the completion of their visits.
This launch occurs in tandem with the closing stages of the 2026 Long-Term Research Fellowships (LTRF), which cater to early-career researchers. By offering both LTRF and the new VISIT grants, the ERS has created a comprehensive "lifecycle" of funding that supports respiratory professionals from their first research projects through to their established mid-career peaks.
Supporting Data: The Vital Need for Mid-Career Support
The "mid-career gap" is a recognized phenomenon in academia and clinical medicine. According to recent workforce analysis within the respiratory field, professionals in this stage are often the primary drivers of innovation, yet they frequently encounter a plateau in funding opportunities. Early-career grants are abundant, and senior-level grants are often tied to major, multi-year projects. The mid-career demographic—those with 5 to 15 years of experience—is often where the highest risk of "professional burnout" or stagnation occurs.
Research from the European health sector suggests that:
- Innovation Stagnation: Without exposure to new laboratory environments or clinical workflows, the pace of scientific discovery in mid-career cohorts tends to slow.
- Global Inequality: Data indicates that researchers in lower-income settings often lack the resources to travel for specialized training, which the VISIT programme seeks to mitigate through its inclusive eligibility policy.
- Collaborative ROI: Studies on medical exchanges demonstrate that even short-term visits (2–4 weeks) significantly increase the likelihood of future co-authored publications and international grant applications, providing a high return on investment for the funding body.
Official Responses: Fostering a Global Community
Dr. Agnes Boots, the ERS Fellowships and Awards Director, emphasized the strategic necessity of this new initiative. In her formal address during the launch, she highlighted the broader philosophy that governs ERS grant-making.
"We are incredibly excited to launch the all-new VISIT Grants," Dr. Boots remarked. "This programme was designed with a specific purpose: to support mid-career respiratory professionals who are navigating the delicate transition between career stages. This is a time when they are refining their expertise, and they deserve the resources to do so outside the familiar confines of their home institution."
Dr. Boots further elaborated on the role of mobility in modern medicine: "ERS grants and fellowships are not merely about funding individual research; they are about promoting science, education, equity, and inclusion. By facilitating these visits, we are essentially building a bridge between institutions, countries, and continents. We want our fellows to bring back not just new techniques, but new perspectives on how we can improve healthcare delivery and patient advocacy."
The response from the wider medical community has been largely positive, with many clinical leads noting that the flexibility of a one-month grant is far more manageable for busy clinicians than a year-long sabbatical, making this an attractive option for practitioners who maintain heavy patient caseloads.
Implications: The Future of Respiratory Health
The launch of the VISIT Grants programme is set to have profound implications for the respiratory health landscape over the next decade.
1. Strengthening Global Health Security
By encouraging the flow of knowledge across borders, the ERS is effectively helping to standardize high-quality care. When a clinician from a resource-limited setting spends a month in a state-of-the-art European research center, they return home with the knowledge to implement better diagnostic and therapeutic standards, thereby reducing global health disparities.
2. Accelerating Translational Research
The gap between "bench and bedside" remains a significant hurdle in respiratory medicine. The VISIT programme encourages researchers to visit clinical settings, and clinicians to visit research labs. This integration is vital for translating basic science findings into tangible treatments for conditions like idiopathic pulmonary fibrosis or severe asthma.
3. Creating a Sustainable Professional Network
The most enduring impact of the VISIT programme will likely be the professional networks it creates. These one-month visits are the "seed corn" for future international partnerships. As these mid-career professionals advance into senior leadership positions, they will carry these networks with them, ensuring that the respiratory community remains a tightly knit, collaborative global force.
4. Adapting to the Digital Age
While the VISIT programme focuses on in-person mobility, it complements the growing digital infrastructure of the ERS. It is expected that the relationships formed during these physical visits will be maintained through virtual collaboration platforms, allowing for a hybrid model of international engagement that persists long after the month-long visit concludes.
Conclusion
As the deadline of 31 October 2026 approaches, the respiratory community is poised to take full advantage of this new opportunity. The VISIT Grants programme stands as a testament to the ERS’s proactive approach to professional development. By investing in the individuals who are currently the "engine room" of respiratory medicine, the ERS is ensuring that the future of the field is defined by collaboration, innovation, and a relentless commitment to improving patient outcomes on a global scale.
For those interested in shaping the future of their career and the field of respiratory medicine, the VISIT programme offers not just a travel grant, but a gateway to a lifetime of international professional synergy.
For further details on how to apply, eligibility documentation, and information on other funding opportunities, visit the official ERS website.
